An Indian American professor, Kattesh Katti, and his research team at the University of Missouri have partnered with Tamil Nadu-based company Dhanvantari Nano Ayushadi in hopes of revolutionizing Ayurvedic medicine.
Ayurvedic medicine, also called Ayurveda, is a holistic medicine system originated in India thousands of years ago that uses herbal compounds, special diets and other healthcare practices to further help conventional preventative and disease treatments, according to a Missouri news release.
Katti and his team have developed a non-toxic delivery method using gold nanoparticles that may revolutionize Ayurveda, the news release said. His technique for producing the nanoparticles was licensed by Dhanvantari Nano Ayushadi.
The medicine uses different combinations of chemicals from natural herbs, spices, fruits and vegetables in combination with metals such as gold, silver and copper, the university said
The combinations strive to treat a number of disorders.
“In the past, metals predominantly used in holistic medicine have been crushed and burned; caregivers grind the ash with herbs to produce an ingestible treatment,” Katti, the curators distinguished professor of radiology and physics in the MU School of Medicine and the College of Arts and Science and senior research scientist at the University of Missouri Research Reactor, said in a statement.
“However, the ways in which those metals are procured often involve mercury; other toxic means to extract the gold or other alloys can be deadly if ingested in the wrong amounts. The gold nanoparticle production methods use a green technology that effectively eliminates the toxicity associated with these treatments,” Katti added.
The research team developed green nanotechnologies to produce phytonano medicines — the compounds used to form Ayurvedic medicine. The therapies are less toxic to the body and could provide alternatives to current treatments for diseases including cancer, arthritis and diabetes among others, the news release noted.
The technology is patent pending.
“These successful production runs within the DNA premises and the efficient training of our personnel fully fulfill the requirements signed in our contract,” Abhaya Kumar Jain, chief executive of DNA, said in a statement.
“We look forward to a long-term working and collaborative relationship with Dr. Katti and his team as we collectively advance the field of nano-Ayurvedic medicine to develop the next generation of health care products for the care and treatment of patients across the world,” Jain added.
Research and product development using the green nanotechnology techniques developed in Katti’s lab will continue at the facility in India, according to the university.
Using Indian Ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy guidelines, DNA will continue to test formulations that could provide complementary therapies to chemotherapy, radiation and other traditional treatments, Katti said in the report.
“We are excited that two great minds, Mr. Abhaya Kumar Jain, a pioneer in the Indian pharmaceutical industry, and Professor Kattesh V Katti, globally recognized as the ‘father of green nanotechnology,’ have come together to bring nano-Ayurvedic medicine technology to India,” Anantkumar Hegde, an elected member of the Indian Parliament, said in the report.
Added Katti in the report, “The nano-Ayurvedic medicine approaches are built on rigorous scientifically validated methods. I am excited to be a part of this important journey using nano-Ayurvedic medicine approaches for treating, healing and curing various diseases. I have always dreamed of helping humanity through my science, I can now see that I am able to use my interdisciplinary green nanotechnology approaches for the development of Ayurvedic products.”
No comments:
Post a Comment